B.3 Price Cost Schedule - UPDATED v.3.xlsx
XLSX spreadsheet 15 KB Posted
- Solicitation number
- 36C26226Q0334
About this file
This is a Price Cost Schedule (Version 3) for a radiopharmaceutical supply contract with the Department of Veterans Affairs. The spreadsheet provides the pricing template that contractors must use to submit quotes for supplying various radiopharmaceuticals to VA Phoenix and VA Tucson Healthcare Systems in Arizona under Solicitation Number 36C26226Q0334. The schedule lists 59 line items covering a comprehensive range of radiopharmaceutical products, including Tc99m-based compounds (Pertechnetate, MDP, Sulfur Colloid, DTPA, MAA, and others), iodine isotopes (I-123 and I-131 capsules and sources), xenon products, indium compounds, gallium products, fluorine-18 FDG in both multi-dose vial and unit dose formats, and copper and gallium radiopharmaceuticals. The template requires contractors to provide unit pricing (Base Pricing, OY1 Pricing, and OY2 Pricing columns) and extended costs for estimated quantities across a Base year plus two Option years performance period.
The contract is structured as a firm fixed-price single award Indefinite Delivery Indefinite Quantity (IDIQ) covering multiple VA stations, with each station issuing annual delivery orders based on estimated requirements. All pricing must include FOB Destination shipping costs. Contractors must be Original Equipment Manufacturers, authorized dealers, authorized distributors, or authorized resellers with verification letters from the OEM on manufacturer letterhead. The file reflects Amendment 0003, which revised the Period of Performance to Base year plus two Option years, deleted the Quadramet line item, and clarified F-18 FDG requirements for both multi-dose vials compatible with Bayer/MEDRAD systems and unit doses. Contractors are responsible for accurate calculations and maintaining the Excel format, and all previous submissions were rendered invalid requiring resubmission acknowledging receipt of Amendment 0003.
View the file
Other files
| File | Type | Posted |
|---|---|---|
| 36C26226Q0334 0003.docx | DOCX document | |
| B.3 Price Cost Schedule - UPDATED v.2.xlsx | XLSX spreadsheet | |
| 36C26226Q0334 0002.docx | DOCX document | |
| B.3 Price Cost Schedule - UPDATED.xlsx | XLSX spreadsheet | |
| 36C26226Q0334 0001.docx | DOCX document | |
| 36C26226Q0334.docx | DOCX document | |
| B.3 Price Cost Schedule.xlsx | XLSX spreadsheet |
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Sheet1
| Description/Part Number* | Estimated Qty | Base Pricing | Base Extended Cost | OY1 Pricing | OY1 Extended Cost | OY2 Pricing | OY2 Extended Cost |
| Tc99m Pertechnetate | 84 | $ - 0 | $ - 0 | $ - 0 | |||
| Tc99m MDP | 188 | $ - 0 | $ - 0 | $ - 0 | |||
| Tc99m Sulfur Colloid Egg | 231 | $ - 0 | $ - 0 | $ - 0 | |||
| Tc99m DTPA | 1 | $ - 0 | $ - 0 | $ - 0 | |||
| Tc99m DTPA aerosol | 1 | $ - 0 | $ - 0 | $ - 0 | |||
| Tc99m MAA reduced particles | 290 | $ - 0 | $ - 0 | $ - 0 | |||
| Tc99m MAA | 288 | $ - 0 | $ - 0 | $ - 0 | |||
| I-123 Capsule 100uCi | 161 | $ - 0 | $ - 0 | $ - 0 | |||
| I-123 Capsule 200uCi | 164 | $ - 0 | $ - 0 | $ - 0 | |||
| I-123 Capsule 400uCi | 1 | $ - 0 | $ - 0 | $ - 0 | |||
| I-131 Capsule | 1 | $ - 0 | $ - 0 | $ - 0 | |||
| I-131 Capsule per mCi | 1 | $ - 0 | $ - 0 | $ - 0 | |||
| I-131 Source | 1 | $ - 0 | $ - 0 | $ - 0 | |||
| Xe-133 (10mCi) | 1 | $ - 0 | $ - 0 | $ - 0 | |||
| Xe-133 (20mCi) | 1 | $ - 0 | $ - 0 | $ - 0 | |||
| Tc99m Pertechnetate bulk | 1 | $ - 0 | $ - 0 | $ - 0 | |||
| Tc99m Sulfur Colloid (Liver, bone marrow) | 8 | $ - 0 | $ - 0 | $ - 0 | |||
| Tc99m Filtered Sulfur Colloid Lymph | 1 | $ - 0 | $ - 0 | $ - 0 | |||
| Tc99m non-Filtered Sulfur Colloid Lymph | 1 | $ - 0 | $ - 0 | $ - 0 | |||
| Tc99m Choletec/Mebrofenin | 443 | $ - 0 | $ - 0 | $ - 0 | |||
| In-111 DTPA vial | 1 | $ - 0 | $ - 0 | $ - 0 | |||
| Ultratag kits | 44 | $ - 0 | $ - 0 | $ - 0 | |||
| Tc99m Sestamibi Parathyroid | 38 | $ - 0 | $ - 0 | $ - 0 | |||
| Tc99m Cardiolite | 1 | $ - 0 | $ - 0 | $ - 0 | |||
| Tc99m Myoview | 7879 | $ - 0 | $ - 0 | $ - 0 | |||
| Tc99m Ceretec Brain | 1 | $ - 0 | $ - 0 | $ - 0 | |||
| Tc99m MAG3 | 140 | $ - 0 | $ - 0 | $ - 0 | |||
| Tc99m DMSA | 1 | $ - 0 | $ - 0 | $ - 0 | |||
| Tc99m HMPAO WBC | 1 | $ - 0 | $ - 0 | $ - 0 | |||
| Ga-67 per mCi | 1 | $ - 0 | $ - 0 | $ - 0 | |||
| Tc99m Pertechnetate | 40 | $ - 0 | $ - 0 | $ - 0 | |||
| Instavent kit | 1 | $ - 0 | $ - 0 | $ - 0 | |||
| Aerovent | 1 | $ - 0 | $ - 0 | $ - 0 | |||
| Tc99m Pyrophosphate | 20 | $ - 0 | $ - 0 | $ - 0 | |||
| Cold Pyrophasphate | 1 | $ - 0 | $ - 0 | $ - 0 | |||
| In-111 Pentreotide UD | 1 | $ - 0 | $ - 0 | $ - 0 | |||
| In-111 Chloride source | 1 | $ - 0 | $ - 0 | $ - 0 | |||
| In-111 WBC Oxine | 1 | $ - 0 | $ - 0 | $ - 0 | |||
| I-123 MIBG | 1 | $ - 0 | $ - 0 | $ - 0 | |||
| Cu-64 DOTATATE | 52 | $ - 0 | $ - 0 | $ - 0 | |||
| I-131 Albumin Source | 1 | $ - 0 | $ - 0 | $ - 0 | |||
| I-131 Albumin Syringe | 1 | $ - 0 | $ - 0 | $ - 0 | |||
| I-131 Albumin Source | 1 | $ - 0 | $ - 0 | $ - 0 | |||
| I-131 Albumin Blood Volume Analysis | 1 | $ - 0 | $ - 0 | $ - 0 | |||
| Tc99m Neurolite | 1 | $ - 0 | $ - 0 | $ - 0 | |||
| Xenon Conv Kit SS Mask w/DD, Fltr, Tbg | 1 | $ - 0 | $ - 0 | $ - 0 | |||
| Soda Lime CO2 Absorber 1lb | 1 | $ - 0 | $ - 0 | $ - 0 | |||
| Drierite 1lb | 1 | $ - 0 | $ - 0 | $ - 0 | |||
| Cu-64 Dotatate UD | 1 | $ - 0 | $ - 0 | $ - 0 | |||
| F-18 FDG multi-dose vial for Bayer/MEDRAD | 1150 | $ - 0 | $ - 0 | $ - 0 | |||
| F 18 FDG unit dose | 593 | $ - 0 | $ - 0 | $ - 0 | |||
| F-18 Sodium Fluoride | 1 | $ - 0 | $ - 0 | $ - 0 | |||
| F-18 Calibration Dose | 1 | $ - 0 | $ - 0 | $ - 0 | |||
| Ga-68 DOTATATE | 110 | $ - 0 | $ - 0 | $ - 0 | |||
| Ga-68 Locametz | 86 | $ - 0 | $ - 0 | $ - 0 | |||
| Ga-68 Illucix | 239 | $ - 0 | $ - 0 | $ - 0 | |||
| Estimated Total Cost per Year | $ - 0 | $ - 0 | $ - 0 | ||||
| Estimated Total Contract Value for B+4 | $ - 0 |
File details come from the government source that posted it. Updated .